160 related articles for article (PubMed ID: 19254698)
1. Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway.
Awazawa M; Ueki K; Inabe K; Yamauchi T; Kaneko K; Okazaki Y; Bardeesy N; Ohnishi S; Nagai R; Kadowaki T
Biochem Biophys Res Commun; 2009 Apr; 382(1):51-6. PubMed ID: 19254698
[TBL] [Abstract][Full Text] [Related]
2. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
3. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes.
Chen H; Zhang L; Li X; Li X; Sun G; Yuan X; Lei L; Liu J; Yin L; Deng Q; Wang J; Liu Z; Yang W; Wang Z; Zhang H; Liu G
J Steroid Biochem Mol Biol; 2013 Nov; 138():445-54. PubMed ID: 23994141
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts.
Fang X; Palanivel R; Zhou X; Liu Y; Xu A; Wang Y; Sweeney G
J Mol Endocrinol; 2005 Dec; 35(3):465-76. PubMed ID: 16326833
[TBL] [Abstract][Full Text] [Related]
7. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
8. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats.
Rodríguez A; Catalán V; Becerril S; Gil MJ; Mugueta C; Gómez-Ambrosi J; Frühbeck G
Life Sci; 2008 Oct; 83(15-16):540-9. PubMed ID: 18761357
[TBL] [Abstract][Full Text] [Related]
9. LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells.
Imai K; Inukai K; Ikegami Y; Awata T; Katayama S
Biochem Biophys Res Commun; 2006 Dec; 351(3):595-601. PubMed ID: 17083919
[TBL] [Abstract][Full Text] [Related]
10. S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet.
Esfandiari F; You M; Villanueva JA; Wong DH; French SW; Halsted CH
Alcohol Clin Exp Res; 2007 Jul; 31(7):1231-9. PubMed ID: 17577393
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.
Kubota N; Yano W; Kubota T; Yamauchi T; Itoh S; Kumagai H; Kozono H; Takamoto I; Okamoto S; Shiuchi T; Suzuki R; Satoh H; Tsuchida A; Moroi M; Sugi K; Noda T; Ebinuma H; Ueta Y; Kondo T; Araki E; Ezaki O; Nagai R; Tobe K; Terauchi Y; Ueki K; Minokoshi Y; Kadowaki T
Cell Metab; 2007 Jul; 6(1):55-68. PubMed ID: 17618856
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and alcoholic fatty liver disease.
Rogers CQ; Ajmo JM; You M
IUBMB Life; 2008 Dec; 60(12):790-7. PubMed ID: 18709650
[TBL] [Abstract][Full Text] [Related]
14. Alcohol and lipid metabolism.
Crabb DW; Liangpunsakul S
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S56-60. PubMed ID: 16958674
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism.
Oh KJ; Park J; Lee SY; Hwang I; Kim JB; Park TS; Lee HJ; Koo SH
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E624-32. PubMed ID: 21224484
[TBL] [Abstract][Full Text] [Related]
16. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
17. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver.
García-Villafranca J; Guillén A; Castro J
Biochimie; 2008 Mar; 90(3):460-6. PubMed ID: 17997005
[TBL] [Abstract][Full Text] [Related]
18. Infusion of a lipid emulsion modulates AMPK and related proteins in rat liver, muscle, and adipose tissues.
Anavi S; Ilan E; Tirosh O; Madar Z
Obesity (Silver Spring); 2010 Jun; 18(6):1108-15. PubMed ID: 20057367
[TBL] [Abstract][Full Text] [Related]
19. Role of S6K1 in regulation of SREBP1c expression in the liver.
Li S; Ogawa W; Emi A; Hayashi K; Senga Y; Nomura K; Hara K; Yu D; Kasuga M
Biochem Biophys Res Commun; 2011 Aug; 412(2):197-202. PubMed ID: 21806970
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
